Late Breaking Abstract - Reslizumab vs benralizumab in patients with inadequately controlled asthma: a Bayesian network meta-analysis

被引:1
|
作者
Casale, Thomas
Mesana, Laura
Pacou, Maud
Farge, GaeLle
Sun, Shawn X.
Castro, Mario
机构
关键词
D O I
10.1183/1393003.congress-2017.OA2903
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OA2903
引用
收藏
页数:1
相关论文
共 50 条
  • [21] LATE-BREAKING ABSTRACT: Network-based meta-analysis of lung, sputum and blood transcriptomics in COPD
    Canet, Maria Rosa Faner
    Morrow, Jarrett
    Noell, Guillaume
    Lopez-Giraldo, Alejandra
    Cruz, Tamara
    Tal-Singer, Ruth
    Miller, Bruce E.
    Rodriguez-Roisin, Roberto
    Silverman, Ed K.
    Agusti, Alvar
    Hersh, Craig P.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [22] Efficacy and safety of benralizumab for eosinophilic asthma: A systematic review and meta-analysis of randomized controlled trials
    Tian, Bao-ping
    Zhang, Gen-sheng
    Lou, Jian
    Zhou, Hong-bin
    Cui, Wei
    [J]. JOURNAL OF ASTHMA, 2018, 55 (09) : 956 - 965
  • [23] Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma
    Schwefel, Georg
    Bratke, Kai
    Marchewski, Hannes
    Virchow, Johann Christian
    Lommatzsch, Marek
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [24] Reslizumab (RES) in patients (pts) with inadequately controlled asthma and elevated blood eosinophils (EOS): Analysis of two phase 3, placebo-controlled trials
    Virchow, Johann Christian
    Zangrilli, James
    Weiss, Sivan
    Korn, Stephanie
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [25] Impact of benralizumab on asthma control, asthma-related quality of life and lung function in patients with poorly controlled eosinophilic asthma: A systematic review and meta-analysis
    Mahdavian, Masoud
    Brothers, Cassidy
    Asghari, Shabnam
    Mallay, Sarah
    Pike, Jordan
    [J]. CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2019, 3 (02) : 106 - 111
  • [26] Late Breaking Abstract - SHAMAL: reduction of maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab: a randomised phase 4 study
    Jackson, David J.
    Heaney, Liam G.
    Humbert, Marc
    Kent, Brian D.
    Hiljemark, Lina
    Olinger, Lynda
    Cohen, David
    Menzies-Gow, Andrew
    Korn, Stephanie
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [27] Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis
    Di Marco, Fabiano
    Calzetta, Luigino
    Rogliani, Paola
    Blasi, Francesco
    Centanni, Stefano
    Micheletto, Claudio
    Rossi, Andrea
    Cazzola, Mario
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [28] Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis
    Kyriakopoulos, Chris
    Ntritsos, Georgios
    Gogali, Athena
    Milionis, Charalampos
    Evangelou, Evangelos
    Kostikas, Konstantinos
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [29] A network meta-analysis to assess options for treatment intensification for patients with type 2 diabetes inadequately controlled on dual therapy
    Schroeder, M.
    Taieb, V.
    Pacou, M.
    Ho, S.
    Nielsen, A. T.
    Schubert, A.
    Neslusan, C.
    [J]. DIABETOLOGIA, 2015, 58 : S347 - S347
  • [30] Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis
    Migliorini, Filippo
    Maffulli, Nicola
    Knobe, Matthias
    Tenze, Giacomo
    Aljalloud, Ali
    Colarossi, Giorgia
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)